Senores Pharmaceuticals has announced a board meeting to consider the financial results for the quarter and half-year.

The company has acquired 7,914 equity shares of Havix Group Inc. (Aavis Pharmaceuticals) and is awaiting RBI approval to complete the acquisition of the remaining 540 shares, with the approval timeline extended by 60 days.

No new financial impact disclosed.